ZERONA
Zerona is the only non-invasive, body slimming, no heat, no pain laser with proven results for fat melting & inch loss. Zerona® utilizes the Erchonia® Laser Scanner, the safest and most researched low-level laser in the world.
Zerona is the first device to appreciate the endocrine function of the adipocyte by delivering an aesthetic treatment designed to provide patients with a meaningful slimming without inducing cell death. Why is this important? Hypertrophic adipocytes are associated with cardiovascular conditions including hypercholesterolemia (high cholesterol) and hyperlipidemia (high lipid counts). Furthermore, enlarged fat mass is directly associated with the nearly 200 million individuals worldwide with diabetes mellitus. By reducing adipose tissue mass without destroying it, Zerona has demonstrated unprecedented medical benefits. Independent research clinics have observed the reduction of serum cholesterol, LDL, HDL, triglyceride, fasting glucose, and hemoglobin A1C following Zerona. In short, by reducing the mass of these cells without destroying or removing them, they are better left to perform these important functions.
Doctor OZ featured Zerona, calling it the “fat fighting miracle procedure” when he talked about ways to get rid of fat in order to slim down and get ready for summer.
Voted #1 Med Spa in The Woodlands by Living Mag!
The Drs. on CBSProfessor Tina Karu, MD explained the results, concluding, “that one key event among the secondary reactions of cellular responses was the change in overall redox state of the irradiated cell,” so “that the cellular response is weak or absent when the overall redox potential of a cell is optimal or near-optimal for the particular growth conditions, and stronger when the redox potential of the target cell is initially shifted to a more reduced state.”
In an episode of The Real Housewives of Beverly Hills, Kyle Richards attended “Paul’s Night of Beauty” at Dr. Paul Nassif’s Beverly Hills Cosmetic Surgery office, and underwent her first Zerona laser treatment.
Initially designed and FDA approved for use during liposuction, the non-invasive Erchonia laser is applied to emulsify the adipose tissue and release excess fat into the interstitial space. From there, fat is passed through the body during its normal course of detoxification.
These remarkable images demonstrate the low-level laser’s ability to emulsify adipose tissue. The pictures highlight the safe collapse of the rigid adipose cell and the secretion of triglycerides and fatty acid from the cell. These images show the formation of a transitory pore forming in the bi-lipid membrane of an adipose cell.
This pore is the direct result of safe, low-level laser stimulation and the reason why the triglycerides and fatty acids are able to move into the interstitial space. The tiny pore causes no damage to the cell. It simply allows the fatty content to safely evacuate the cell. Treatment with the Zerona laser is easy and painless. Each session takes less only forty minutes; this makes for easy scheduling to meet your needs. The laser is applied to the targeted area, which for many is a combination of the waist, hips, and thighs, for 20 minutes. Then you turn over and the very same treatment is applied to the opposite side.
The minimum suggested treatment period is two weeks, with three full sessions each week. At Body BeneFits, we were first to recommend three and four-week treatment schedules for the best results; however many people have found they are satisfied with their results in just two weeks.
The session is relaxing and has been described as even Zen-like. Some even try to catch up on phone calls with friends and loved ones as they lay down. You simply lay on a comfortable, warmed bed for twenty minutes at a time, in a private and relaxed environment, while the cold laser does all of the work. Since the Zerona uses cold laser technology, you feel nothing during the procedure.
A double-blind, randomized, placebo-controlled trial of a 2-week noninvasive laser treatment conducted from May 2007 to June 2008 across multiple-private practice sites in the United States of America. Sixty-seven volunteers between the ages of 18–65 with a body mass index (BMI) between 25 and 30 kg/m2 and who satisfied the set inclusion criteria participated. Eight of the 67 subjects did not have circumference measurements recorded at the 2-week post-procedure measurement point. Participants were randomly assigned to receive low-level laser treatments or a matching sham treatment three times per week for 2 weeks. Reduction in the total combined inches of circumference measurements of the waist, hip and bilateral thighs from baseline to the completion of the 2-week procedure administration phase was assessed.
